Patents by Inventor Neil Keith ADLINGTON

Neil Keith ADLINGTON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12134613
    Abstract: This specification generally relates to an improved method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine (I), or pharmaceutically acceptable salts thereof; polymorphic forms thereof, and intermediates useful in the manufacture of such compounds and salts thereof.
    Type: Grant
    Filed: September 10, 2019
    Date of Patent: November 5, 2024
    Assignees: AstraZeneca AB, Hutchison Medipharma Limited
    Inventors: Andrew Roy Turner, Andrew Timothy Turner, Gareth Paul Howell, Malcolm Allan Young Gall, Keith Raymond Mulholland, Neil Keith Adlington, Zhenping Tian, Bo Liu, Qisun Gong, Wei Yu
  • Publication number: 20220048904
    Abstract: This specification generally relates to an improved method for the manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine (I), or pharmaceutically acceptable salts thereof, polymorphic forms thereof, and intermediates useful in the manufacture of such compounds and salts thereof.
    Type: Application
    Filed: September 10, 2019
    Publication date: February 17, 2022
    Inventors: Andrew Roy TURNER, Andrew Timothy TURNER, Gareth Paul HOWELL, Malcolm Allan Young GALL, Keith Raymond MULHOLLAND, Neil Keith ADLINGTON, Zhenping TIAN, Bo LIU, Qisun GONG, Wei YU